We are live on ! Find out more
AA

Altrafin AG Portfolio holdings

AUM $255M
1-Year Est. Return 21.67%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+21.67%
3 Year Est. Return
+97.62%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$296M
AUM Growth
+$38.9M
Cap. Flow
+$4.7M
Cap. Flow %
1.59%
Top 10 Hldgs %
57.87%
Holding
52
New
7
Increased
21
Reduced
18
Closed
2

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$2.71M
2
FISV
Fiserv Inc
FISV
+$1.92M
3
FICO icon
Fair Isaac
FICO
+$1.79M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.62M
5
MRVL icon
Marvell Technology
MRVL
+$1.4M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$5.33M
2
HON icon
Honeywell
HON
+$994K
3
CVX icon
Chevron
CVX
+$965K
4
AMD icon
Advanced Micro Devices
AMD
+$904K
5
SHEL icon
Shell
SHEL
+$852K

Sector Composition

Rank Sector Weight
1 Technology 38.7%
2 Financials 23.16%
3 Communication Services 12.95%
4 Consumer Discretionary 10.04%
5 Healthcare 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
51
Walt Disney
DIS
$189B
– –
-2,818
Closed -$278K
1 2
3

Similar funds

TPF
Tribridge Partners Financial Columbia, Maryland $255M AUM 14.36% 1-Year Est. Return
MAM
Mainsail Asset Management Birmingham, Alabama $255M AUM 18.22% 1-Year Est. Return
CWA
Carolina Wealth Advisors Myrtle Beach, South Carolina $255M AUM 17.72% 1-Year Est. Return
TFG
Tull Financial Group Chesapeake, Virginia $256M AUM 17.42% 1-Year Est. Return
PCM
Politan Capital Management New York $255M AUM 62.37% 1-Year Est. Return
VIPI
Vista Investment Partners II Richmond, Indiana $255M AUM 32.07% 1-Year Est. Return
SWM
Shelton Wealth Management Fort Worth, Texas $255M AUM 34.47% 1-Year Est. Return
SFC
Sprinkle Financial Consultants Littleton, Colorado $255M AUM 21.91% 1-Year Est. Return

Altrafin AG's Q2 2025 Portfolio in Review

As of Q2 2025, Altrafin AG held 52 positions worth $296M, up 15% from $257M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Altrafin AG's Q2 2025 filing shows 7 new, 21 increased, 18 reduced and 2 closed positions. Its largest new stake was Fair Isaac: 952 shares worth $1.74M. The largest sale was UnitedHealth, an estimated $5.33M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 34% a quarter earlier, followed by Financials and Communication Services.

  • Altrafin AG's largest Q2 2025 buy was Fair Isaac: 952 shares worth $1.74M.
  • Altrafin AG added most to Novo Nordisk in Q2 2025, an estimated $2.71M increase.
  • Altrafin AG's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $5.33M.
  • Altrafin AG fully exited Chevron in Q2 2025, selling an estimated $965K.
  • Altrafin AG's ten largest holdings make up 58% of its $296M portfolio in Q2 2025.
  • Altrafin AG opened 7 new positions and closed 2 in Q2 2025.
  • Altrafin AG's portfolio value rose 15% quarter-over-quarter to $296M.

Based on Altrafin AG's 13F filing for Q2 2025, filed 17 Feb 2026.